Further reading:
Kacen, A. et al. Post-translational modifications reshape the antigenic landscape of the MHC I immunopeptidome in tumors. Nat Biotechnol 41, 239-251 (2022)
Bartok, O. et al. Anti-tumor immunity induces aberrant peptide presentation in melanoma. Nature 590, 332-337 (2021)
Kalaora, S. et al. Identification of bacteria-derived HLA-bound peptides in melanoma. Nature 592, 138-143 (2021)
Levy, R. et al. Large-Scale Immunopeptidome Analysis Reveals Recurrent Posttranslational Splicing of Cancer- and Immune-Associated Genes. Mol Cell Proteomics 22, 100519 (2023)
